Flow Cytometry Market Size, Share, Industry Growth & Forecast to 2027

Global Flow Cytometry Market Size, Share, Growth, Industry Trends, Competitive Analysis and Forecast to 2030

Report ID: RC3721 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: June 10th, 2023

The global flow cytometry market size is expected to grow at a higher CAGR of 9% during the forecast period from 2021 to 2027 and valued at USD 6.26 billion in 2020. The increasing incidence of chronic disorders across the globe is a primary factor driving the market growth. Furthermore, the increasing prevalence of targeted diseases and increasing investment in research development in biotechnology is anticipated to fuel the market over the forecast period.

Moreover, the increasing side effects associated with chemotherapy and radiation therapy in cancer care is expected to boost the market growth. As per the World Cancer Research Fund (WCRF), around 18 million people were diagnosed with cancer disease in 2018. In addition, 437,033 people were suffered from leukemia in 2018, WCRF shared in its research papers.

Market Drivers:

Increasing Applications in Research and Clinical Settings: Flow cytometry is a versatile technology widely used in various fields of research, including immunology, cancer biology, stem cell research, and drug discovery. It is also utilized in clinical settings for diagnostics, monitoring disease progression, and assessing treatment efficacy. The expanding applications of flow cytometry drive the demand for flow cytometry instruments and reagents.

Technological Advancements and Product Innovations: Continuous advancements in flow cytometry technologies have resulted in improved instrument performance, higher sensitivity, and enhanced capabilities. Innovations such as multiparameter analysis, high-throughput analysis, and imaging flow cytometry have expanded the applications and utility of flow cytometry. Technological advancements and product innovations drive the adoption of flow cytometry systems.

Growing Focus on Personalized Medicine: The shift towards personalized medicine, which aims to tailor medical treatments to individual patients based on their unique characteristics, has increased the demand for advanced diagnostic tools. Flow cytometry enables the characterization and analysis of individual cells, allowing for precise diagnosis, treatment selection, and monitoring of patient response. The growing focus on personalized medicine drives the adoption of flow cytometry in clinical practice.

Rising Incidence of Chronic and Infectious Diseases: The increasing prevalence of chronic and infectious diseases, such as cancer, HIV/AIDS, and autoimmune disorders, creates a significant demand for advanced diagnostic tools and monitoring techniques. Flow cytometry provides valuable insights into disease mechanisms, immune cell profiling, and therapeutic response evaluation, contributing to the management and treatment of these diseases.

Growing Biopharmaceutical Industry: The biopharmaceutical industry is experiencing significant growth, driven by factors such as an aging population, increasing healthcare expenditure, and a rise in chronic diseases. Flow cytometry is extensively used in biopharmaceutical research and development processes, including target identification, antibody screening, and cell line development. The growth of the biopharmaceutical industry contributes to the demand for flow cytometry instruments and services.

Increasing Adoption of Companion Diagnostics: Companion diagnostics are tests used to identify patients who are likely to benefit from specific therapies or treatments. Flow cytometry plays a crucial role in companion diagnostics by providing information about cellular markers, biomarkers, and molecular profiling. The increasing adoption of companion diagnostics in precision medicine drives the demand for flow cytometry technologies.

Growing Investments in Life Sciences and Research: Increased investments in life sciences research, both from public and private sectors, fuel the demand for advanced research tools such as flow cytometry. Funding for academic research, government initiatives, and collaborations between research institutions and industry players contribute to the growth of the flow cytometry market.

Rising Awareness and Adoption of Immunotherapy: Immunotherapy, which harnesses the body’s immune system to fight diseases such as cancer, has gained significant attention and adoption in recent years. Flow cytometry is crucial for immune cell profiling, monitoring immune responses, and assessing immunotherapy efficacy. The growing awareness and adoption of immunotherapy contribute to the demand for flow cytometry in immunological research and clinical applications.

Market Outlook:

Benchmark Year		2022
Market Size		> USD 6 Billion by 2027
Market Growth (CAGR)		9% (2023-2030)
Largest Market Share		North America
Analysis Period		2020-2030
Market Players		Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, and Agilent Technologies, Inc.

Market Insights:

The global flow cytometry market is segmented into product, technology, application, end-use, and geography. On the basis of product, the market is further bifurcated into instruments, reagents & consumables, software, accessories, and services. The instrument segment dominated the market in 2020 and accounted to hold the largest market share over one-third percent of the market in terms of revenue. The segment growth is attributed to technological advancement and the advent of new cytometers by some major players.

Flow Cytometry Market Size & Growth Rate

To know more about the report, request sample papers

By technology, the flow cytometry market is fragmented into cell-based and bead-based technology. The sell-based segment dominated the market in 2020 and expected to grow at the same trend over the forecast period. The increasing awareness regarding early diagnosis and associated benefits of cell-based assays are some major factors to drive the segment growth. On the other hand, the bead-based segment is accounted to hold a significant revenue share around one-fourth percent of the market in 2020. The advancement in molecular engineering and monoclonal antibody production are some factors that contributed the segment growth.

The flow cytometry comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The flow cytometry market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

2018-19 – Historical Year
2020 – Base Year
2021-2027 – Forecast Period

Market Segmentation:

By Product:

Instruments
Reagents & Consumables
Software
Accessories
Services

By Technology:

Cell-based
Bead-based

By Application:

Research
Industrial
Clinical

By End-Use:

Commercial Organizations
Hospitals
Academic Institutes
Clinical Testing Labs

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage:

Geographically, the flow cytometry market report comprises dedicated sections centering on the regional market revenue and trends. The flow cytometry market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The flow cytometry market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Flow cytometry market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Market Competition Assessment:

Key players operating in the global flow cytometry market are Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, and Agilent Technologies, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Danaher Corporation
Becton
Dickinson and Company
Luminex Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Miltenyi Biotec
Sysmex Corporation
Stratedigm, Inc.
Apogee Flow Systems Ltd.
Sony Biotechnology, Inc.

Key Questions Answered by Flow Cytometry Market Report:

Global flow cytometry market forecasts from 2021-2027
Regional flow cytometry market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Flow cytometry submarket forecasts from 2021-2027 covering the market by product, by technology, by application, by end-use, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the flow cytometry market
Analysis of the key factors driving and restraining the growth of the global, regional, and country-level flow cytometry markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the flow cytometry market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Flow Cytometry Market Portraiture
2.2. Global Flow Cytometry Market, by Product, 2020 (USD Mn)
2.3. Global Flow Cytometry Market, by Technology, 2020 (USD Mn)
2.4. Global Flow Cytometry Market, by Application, 2020 (USD Mn)
2.5. Global Flow Cytometry Market, by End-Use, 2020 (USD Mn)
2.6. Global Flow Cytometry Market, by Geography, 2020 (USD Mn)

3. Global Flow Cytometry Market Analysis

3.1. Flow Cytometry Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

4. Global Flow Cytometry Market By Product, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Instruments
4.3. Reagents & Consumables
4.4. Software
4.5. Accessories
4.6. Services

5. Global Flow Cytometry Market By Technology, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Cell-based
5.3. Bead-based

6. Global Flow Cytometry Market By Application, 2018 – 2027 (USD Mn)

6.1. Overview
6.2. Research
6.3. Industrial
6.4. Clinical

7. Global Flow Cytometry Market By End-Use, 2018 – 2027 (USD Mn)

7.1. Overview
7.2. Commercial Organizations
7.3. Hospitals
7.4. Academic Institutes
7.5. Clinical Testing Labs

8. North America Flow Cytometry Market Analysis and Forecast, 2018 – 2027 (USD Mn)

8.1.1. Overview
8.1.2. North America Flow Cytometry Market by Product (2018-2027 USD Mn)
8.1.3. North America Flow Cytometry Market by Technology (2018-2027 USD Mn)
8.1.4. North America Flow Cytometry Market by Application (2018-2027 USD Mn)
8.1.5. North America Flow Cytometry Market by End-Use (2018-2027 USD Mn)
8.1.6. North America Flow Cytometry Market by Country (2018-2027 USD Mn)
8.1.6.1. U.S.
8.1.6.1.1. U.S. Flow Cytometry Market by Product (2018-2027 USD Mn)
8.1.6.1.2. U.S. Flow Cytometry Market by Technology (2018-2027 USD Mn)
8.1.6.1.3. U.S. Flow Cytometry Market by Application (2018-2027 USD Mn)
8.1.6.1.4. U.S. Flow Cytometry Market by End-Use (2018-2027 USD Mn)
8.1.6.2. Canada
8.1.6.2.1. Canada Flow Cytometry Market by Product (2018-2027 USD Mn)
8.1.6.2.2. Canada Flow Cytometry Market by Technology (2018-2027 USD Mn)
8.1.6.2.3. Canada Flow Cytometry Market by Application (2018-2027 USD Mn)
8.1.6.2.4. Canada Flow Cytometry Market by End-Use (2018-2027 USD Mn)

9. Europe Flow Cytometry Market Analysis and Forecast, 2018 – 2027 (USD Mn)

9.1.1. Overview
9.1.2. Europe Flow Cytometry Market by Product (2018-2027 USD Mn)
9.1.3. Europe Flow Cytometry Market by Technology (2018-2027 USD Mn)
9.1.4. Europe Flow Cytometry Market by Application (2018-2027 USD Mn)
9.1.5. Europe Flow Cytometry Market by End-Use (2018-2027 USD Mn)
9.1.6. Europe Flow Cytometry Market by Country (2018-2027 USD Mn)
9.1.6.1. Germany
9.1.6.1.1. Germany Flow Cytometry Market by Product (2018-2027 USD Mn)
9.1.6.1.2. Germany Flow Cytometry Market by Technology (2018-2027 USD Mn)
9.1.6.1.3. Germany Flow Cytometry Market by Application (2018-2027 USD Mn)
9.1.6.1.4. Germany Flow Cytometry Market by End-Use (2018-2027 USD Mn)
9.1.6.2. U.K.
9.1.6.2.1. U.K. Flow Cytometry Market by Product (2018-2027 USD Mn)
9.1.6.2.2. U.K. Flow Cytometry Market by Technology (2018-2027 USD Mn)
9.1.6.2.3. U.K. Flow Cytometry Market by Application (2018-2027 USD Mn)
9.1.6.2.4. U.K. Flow Cytometry Market by End-Use (2018-2027 USD Mn)
9.1.6.3. France
9.1.6.3.1. France Flow Cytometry Market by Product (2018-2027 USD Mn)
9.1.6.3.2. France Flow Cytometry Market by Technology (2018-2027 USD Mn)
9.1.6.3.3. France Flow Cytometry Market by Application (2018-2027 USD Mn)
9.1.6.3.4. France Flow Cytometry Market by End-Use (2018-2027 USD Mn)
9.1.6.4. Italy
9.1.6.4.1. Italy Flow Cytometry Market by Product (2018-2027 USD Mn)
9.1.6.4.2. Italy Flow Cytometry Market by Technology (2018-2027 USD Mn)
9.1.6.4.3. Italy Flow Cytometry Market by Application (2018-2027 USD Mn)
9.1.6.4.4. Italy Flow Cytometry Market by End-Use (2018-2027 USD Mn)
9.1.6.5. Rest of Europe
9.1.6.5.1. Rest of Europe Flow Cytometry Market by Product (2018-2027 USD Mn)
9.1.6.5.2. Rest of Europe Flow Cytometry Market by Technology (2018-2027 USD Mn)
9.1.6.5.3. Rest of Europe Flow Cytometry Market by Application (2018-2027 USD Mn)
9.1.6.5.4. Rest of Europe Flow Cytometry Market by End-Use (2018-2027 USD Mn)

10. Asia Pacific Flow Cytometry Market Analysis and Forecast, 2018 – 2027 (USD Mn)

10.1.1. Overview
10.1.2. Asia Pacific Flow Cytometry Market by Product (2018-2027 USD Mn)
10.1.3. Asia Pacific Flow Cytometry Market by Technology (2018-2027 USD Mn)
10.1.4. Asia Pacific Flow Cytometry Market by Application (2018-2027 USD Mn)
10.1.5. Asia Pacific Flow Cytometry Market by End-Use (2018-2027 USD Mn)
10.1.6. Asia Pacific Flow Cytometry Market by Country (2018-2027 USD Mn)
10.1.6.1. China
10.1.6.1.1. China Flow Cytometry Market by Product (2018-2027 USD Mn)
10.1.6.1.2. China Flow Cytometry Market by Technology (2018-2027 USD Mn)
10.1.6.1.3. China Flow Cytometry Market by Application (2018-2027 USD Mn)
10.1.6.1.4. China Flow Cytometry Market by End-Use (2018-2027 USD Mn)
10.1.6.2. Japan
10.1.6.2.1. Japan Flow Cytometry Market by Product (2018-2027 USD Mn)
10.1.6.2.2. Japan Flow Cytometry Market by Technology (2018-2027 USD Mn)
10.1.6.2.3. Japan Flow Cytometry Market by Application (2018-2027 USD Mn)
10.1.6.2.4. Japan Flow Cytometry Market by End-Use (2018-2027 USD Mn)
10.1.6.3. Rest of Asia Pacific
10.1.6.3.1. Rest of Asia Pacific Flow Cytometry Market by Product (2018-2027 USD Mn)
10.1.6.3.2. Rest of Asia Pacific Flow Cytometry Market by Technology (2018-2027 USD Mn)
10.1.6.3.3. Rest of Asia Pacific Flow Cytometry Market by Application (2018-2027 USD Mn)
10.1.6.3.4. Rest of Asia Pacific Flow Cytometry Market by End-Use (2018-2027 USD Mn)

11. Latin America (LATAM) Flow Cytometry Market Analysis and Forecast, 2018 – 2027 (USD Mn)

11.1.1. Overview
11.1.2. Latin America Flow Cytometry Market by Product (2018-2027 USD Mn)
11.1.3. Latin America Flow Cytometry Market by Technology (2018-2027 USD Mn)
11.1.4. Latin America Flow Cytometry Market by Application (2018-2027 USD Mn)
11.1.5. Latin America Flow Cytometry Market by End-Use (2018-2027 USD Mn)
11.1.6. Latin America Flow Cytometry Market by Country (2018-2027 USD Mn)
11.1.6.1. Brazil
11.1.6.1.1. Brazil Flow Cytometry Market by Product (2018-2027 USD Mn)
11.1.6.1.2. Brazil Flow Cytometry Market by Technology (2018-2027 USD Mn)
11.1.6.1.3. Brazil Flow Cytometry Market by Application (2018-2027 USD Mn)
11.1.6.1.4. Brazil Flow Cytometry Market by End-Use (2018-2027 USD Mn)
11.1.6.2. Mexico
11.1.6.2.1. Mexico Flow Cytometry Market by Product (2018-2027 USD Mn)
11.1.6.2.2. Mexico Flow Cytometry Market by Technology (2018-2027 USD Mn)
11.1.6.2.3. Mexico Flow Cytometry Market by Application (2018-2027 USD Mn)
11.1.6.2.4. Mexico Flow Cytometry Market by End-Use (2018-2027 USD Mn)
11.1.6.3. Rest of Latin America
11.1.6.3.1. Rest of Latin America Flow Cytometry Market by Product (2018-2027 USD Mn)
11.1.6.3.2. Rest of Latin America Flow Cytometry Market by Technology (2018-2027 USD Mn)
11.1.6.3.3. Rest of Latin America Flow Cytometry Market by Application (2018-2027 USD Mn)
11.1.6.3.4. Rest of Latin America Flow Cytometry Market by End-Use (2018-2027 USD Mn)

12. Middle East and Africa Flow Cytometry Market Analysis and Forecast, 2018 – 2027 (USD Mn)

12.1.1. Overview
12.1.2. MEA Flow Cytometry Market by Product (2018-2027 USD Mn)
12.1.3. MEA Flow Cytometry Market by Technology (2018-2027 USD Mn)
12.1.4. MEA Flow Cytometry Market by Application (2018-2027 USD Mn)
12.1.5. MEA Flow Cytometry Market by End-Use (2018-2027 USD Mn)
12.1.6. Middle East and Africa Flow Cytometry Market, by Country (2018-2027 USD Mn)
12.1.6.1. GCC
12.1.6.1.1. GCC Flow Cytometry Market by Product (2018-2027 USD Mn)
12.1.6.1.2. GCC Flow Cytometry Market by Technology (2018-2027 USD Mn)
12.1.6.1.3. GCC Flow Cytometry Market by Application (2018-2027 USD Mn)
12.1.6.1.4. GCC Flow Cytometry Market by End-Use (2018-2027 USD Mn)
12.1.6.2. Rest of MEA
12.1.6.2.1. Rest of MEA Flow Cytometry Market by Product (2018-2027 USD Mn)
12.1.6.2.2. Rest of MEA Flow Cytometry Market by Technology (2018-2027 USD Mn)
12.1.6.2.3. Rest of MEA Flow Cytometry Market by Application (2018-2027 USD Mn)
12.1.6.2.4. Rest of MEA Flow Cytometry Market by End-Use (2018-2027 USD Mn)

13. Company Profiles

13.1. Danaher Corporation
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Becton
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. Dickinson and Company
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Luminex Corporation
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. Agilent Technologies, Inc.
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Bio-Rad Laboratories, Inc.
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. Miltenyi Biotec
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. Sysmex Corporation
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Stratedigm, Inc.
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. Apogee Flow Systems Ltd.
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis

Fill the given form to inquiry before buying for Flow Cytometry Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$ 6995/- Corporate License